The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sotnikova L.S.

Siberian State Medical University, Ministry of Health of Russia, Tomsk, Russia

Udut E.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet";
FBGU "NII farmakologii SO RAMN";
FBGU "NII psikhicheskogo zdorov'ia SO RAMN";
OOO LDTs "Mezhdunarodnyĭ institut biologicheskikh sistem", Tomsk

Tonkikh O.S.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet";
FBGU "NII farmakologii SO RAMN";
FBGU "NII psikhicheskogo zdorov'ia SO RAMN";
OOO LDTs "Mezhdunarodnyĭ institut biologicheskikh sistem", Tomsk

The use of Vizanne for the treatment of endometriosis and benign breast disease

Authors:

Sotnikova L.S., Udut E.V., Tonkikh O.S.

More about the authors

Journal: Russian Journal of Human Reproduction. 2013;(4): 44‑50

Read: 19383 times

Download PDF (RU)
Contact the author
Table of contents

THE USE OF VIZANNE FOR THE TREATMENT OF ENDOMETRIOSIS AND BENIGN BREAST DISEASE
THE USE OF VIZANNE FOR THE TREATMENT OF ENDOMETRIOSIS AND BENIGN BREAST DISEASE

To cite this article:

Sotnikova LS, Udut EV, Tonkikh OS. The use of Vizanne for the treatment of endometriosis and benign breast disease. Russian Journal of Human Reproduction. 2013;(4):44‑50. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Expe­rience with the use of amitriptyline for chro­nic pelvic pain asso­ciated with endo­metriosis. Russian Journal of Human Reproduction. 2025;(1):86-93
Three-dimensional mode­ling and intraoperative navi­gation in the diagnosis and treatment of various forms of adenomyosis. Russian Journal of Human Reproduction. 2025;(2):92-100
Obje­ctification of Pain in Patients with Endo­metriosis. (Literature review and own data). Russian Journal of Human Reproduction. 2025;(2):62-85
The role of macrophage pola­rization in the deve­lopment of endo­metriosis and the therapeutic pote­ntial of its modu­lation. Russian Journal of Human Reproduction. 2025;(3):20-33
Expe­rimental mode­ling and treatment of endo­metriosis using bovhyaluronidase azoximer in an animal model. Russian Journal of Human Reproduction. 2025;(4):26-40
The influence of gender on the morphometric variability of the medu­lla oblo­ngata and pons in adults, taking into account the type of skull base acco­rding to MRI data. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(1):15-21
Pulmonary arte­rial hype­rtension in diso­rders of porto-caval hemo­dynamics. The role of ultrasound diagnostics. Russian Cardiology Bulletin. 2025;(1):90-98
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
Dyna­mics of permeability of the blood-brain barrier after FUS thalamotomy acco­rding to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60
Role of magnetic reso­nance imaging in dete­cting the signs of inte­rnal caro­tid artery stenosis in the acute period of athe­rothrombotic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):67-73
Abstract:

Authors:

Sotnikova L.S.

Siberian State Medical University, Ministry of Health of Russia, Tomsk, Russia

Udut E.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet";
FBGU "NII farmakologii SO RAMN";
FBGU "NII psikhicheskogo zdorov'ia SO RAMN";
OOO LDTs "Mezhdunarodnyĭ institut biologicheskikh sistem", Tomsk

Tonkikh O.S.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet";
FBGU "NII farmakologii SO RAMN";
FBGU "NII psikhicheskogo zdorov'ia SO RAMN";
OOO LDTs "Mezhdunarodnyĭ institut biologicheskikh sistem", Tomsk

Close metadata

References:

  1. Radzinskii V.E. Molochnye zhelezy i ginekologicheskie bolezni. M 2010; 302.
  2. Filippov O.S. Dobrokachestvennye zabolevaniya molochnykh zhelez: rukovodstvo po diagnostike i lecheniyu. M: Medpress-inform 2007; 54.
  3. Love S.M., Gelman R.S., Silen W. Fibrocystic disease of the breast: a nondisease. N Engl J Med 1982; 307: 1010-1014.
  4. Winkler U.H., Schindler A.E., Brinkmann U.S. et al. Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecol Endocrinol 2001; 15: 6: 37-43.
  5. Brinton L.A., Gridley G., Persson I. et al. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176: 572-579.
  6. Melin A., Sparén P., Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007; 22: 11: 3021-3026.
  7. Bertelsen L. et al. Risk for breast cancer among women with endometriosis. Int J Cancer 2007; 120: 6: 1372-1375.
  8. Adamyan L.V., Kulakov V.I., Andreeva E.N. Endometriozy. M: Meditsina 2006; 416.
  9. Ishchenko A.I., Kudrina E.A. Endometrioz: diagnostika i lechenie. M: MIA 2008; 176.
  10. Giudice L.C. Endometriosis. N Engl J Med 2010; 362: 2389-2398.
  11. Konovalova V.N. Diskussionnye voprosy taktiki vedeniya zhenshchin s disgormonal'nymi zabolevaniyami molochnykh zhelez. Effektivnaya farmakoterapiya. Akush i ginekol 2009; 6: 6-12.
  12. Tsoi L.K. Lekarstvennaya terapiya diffuznoi mastopatii i PMS. Effektivnaya farmakoterapiya. Onkol gematol i radiol 2010; 3: 2-7.
  13. Olawaiye A., Withiam-Leitch M., Danakas G. et al. Mastalgia: a review of management. J Reprod Med 2005; 12: 50: 933-939.
  14. Sitruk-Ware R. New progestagens for contraceptive use. Human Reprod Update 2006; 12: 2: 169-178.
  15. Rozhkova N.I. Rentgenodiagnostika zabolevanii molochnoi zhelezy. Pod red. A.S. Pavlova. M: Meditsina 1993; 227.
  16. Vlasov V.V. Vvedenie v dokazatel'nuyu meditsinu. M: Media Sfera 2001; 392.
  17. Gubler E.V. Informatika v patologii, klinicheskoi meditsine i pediatrii. SPb: Meditsina 2002; 176.
  18. Kohler G., Faustmann T.A., Gerlinger C. et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. Int J Gynecol Obstet 2010; 108: 21-25.
  19. Strowitzki T., Faustmann T., Gerlinger C. et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010; 151: 193-198.
  20. Momoeda M., Taketani Y. Randomized double-blind, multicentre, parallel-group dose-response study of dienogest in patients with endometriosis. Jpn Pharmacol Ther 2007; 35: 769-783.
  21. Shimizu Y., Takeuchi T., Mita S. et al. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression. Mol Hum Reprod 2009; 15: 693-701.
  22. Horie S., Harada T., Mitsunari M. et al. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril 2009; 83: 1530-1535.
  23. Shimizu Y., Mita S., Takeuchi T., Notsu T. et al. Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system. Steroids 2011; 76: 60-67.
  24. Katayama H., Katayama T., Uematsu K. et al. Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model. Hum Reprod 2010; 25: 11: 2851-2858.
  25. Lebovic D.I., Mueller M.D., Taylor R.N. Immunobiology of endometriosis. Fertil Steril 2001; 75: 1-10.
  26. Heald A., Kaushal K., Anderson S. et al. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Gynecol Endocrinol 2005; 20: 176-182.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.